Clinical Trials Logo
  1. Home
  2. Drug Dependence
  3. NCT00005765
  4. Details
NCT00005765 Clinical Trial

Behavioral Economics of Human Drug Self-Administration

Drug Dependence Clinical Trial

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT00005765
Other study ID # NCRR-M01RR00109-0747
Secondary ID M01RR000109
Status Completed
Phase N/A
First received June 1, 2000
Last updated June 23, 2005

Study information
Verified date December 2003
Source National Center for Research Resources (NCRR)
Contact n/a
Is FDA regulated No
Health authority United States: Federal Government
Study type Observational

Clinical Trial Summary

The objective of this protocol is to examine the utility of behavioral economics for understanding reinforcer interactions as they pertain to drug self-administration. In a series of 6 experiments, the researchers will attempt to quantify the effects of qualitatively different reinforcers (money, cigarettes, alcohol, nicotine gum) and their interactions. This work represents a continuation of research by this investigator in the area of addiction and pharmacology.

Recruitment information / eligibility
Status Completed
Enrollment 0
Est. completion date
Est. primary completion date
Accepts healthy volunteers No
Gender Both
Age group 21 Years to 50 Years
Eligibility Inclusion Criteria:

- Use of 20 or more cigarettes per day

- CO levels >15 ppm

- More than 12 alcohol drinks per week and beer as preferred alcoholic beverage

Study Design

Observational Model: Natural History, Time Perspective: Cross-Sectional

Related Conditions & MeSH terms

Intervention

Drug:
• nicotine

• alcohol

Locations
Country Name City State
United States University of Vermont Burlington Vermont

Sponsors (1)
Lead Sponsor Collaborator
National Center for Research Resources (NCRR)

Country where clinical trial is conducted

United States, 

See also
  Status Clinical Trial Phase
Completed NCT02564341 - Targeting Effective Analgesia in Clinics for HIV - Intervention N/A
Completed NCT02224508 - Evaluation of a Health Plan Initiative to Mitigate Chronic Opioid Therapy Risks N/A
Completed NCT00593463 - Drug Discrimination in Methadone-Maintained Humans Study 1 Phase 1
Completed NCT03678051 - CBT4CBT for Women in Residential Treatment for Substance Use Disorders N/A
Recruiting NCT04003948 - Preliminary Efficacy and Safety of Ibogaine in the Treatment of Methadone Detoxification Phase 2
Withdrawn NCT05440721 - Clinical Trial of an Innovative Digital Therapeutic for Smoking Cessation With Biochemical Verification N/A
Completed NCT03694327 - Innovative Digital Therapeutic for Smoking Cessation N/A
Completed NCT01449981 - Development and Testing of Adolescent Twelve-Step Facilitation N/A
Completed NCT00183118 - Russia PREVENT (HIV Prevention Partnership in Russian Alcohol Treatment) Phase 1/Phase 2
Completed NCT00047866 - Brain Function in Response to Motivational Stimuli N/A
Recruiting NCT03333460 - Transcranial Magnetic Stimulation for Cocaine Addiction N/A
Completed NCT02124980 - Automated Recovery Line for Medication Assisted Treatment N/A
Terminated NCT00975416 - Oxytocin and Cognitive Behavioral Therapy in Drug Dependence Phase 4
Completed NCT00265512 - LINK: Aftercare Monitoring Project N/A
Completed NCT00706901 - Impact of Group Motivational Interviewing and In-Home-Messaging-Devices for Dually Diagnosed Veterans N/A
Completed NCT02656745 - Clinical Trial of Smoking Cessation Mobile Phone Program N/A
Withdrawn NCT00675532 - Testing a Primary Care Model for the Treatment of Opioid Dependence Using Long-acting Injectable Naltrexone (Vivitrol). N/A
Active, not recruiting NCT03539575 - CB1R in Synthetic Psychoactive Cannabinoids N/A
Completed NCT01246401 - Naltrexone for Opioid Dependent Released Human Immunodeficiency Virus Positive (HIV+) Criminal Justice Populations Phase 1/Phase 2
Completed NCT01096550 - Intensive Outpatient Versus Outpatient Treatment With Buprenorphine Among African Americans N/A